Emerging Role of GLP-1 Receptor Agonists in Bipolar Disorder Treatment

1 min read
Source: Nature
Emerging Role of GLP-1 Receptor Agonists in Bipolar Disorder Treatment
Photo: Nature
TL;DR

This review explores the potential of glucagon-like peptide-1 (GLP-1) receptor agonists as emerging treatments for bipolar disorder, summarizing preclinical and clinical evidence supporting their therapeutic role in mood regulation, neuroprotection, and metabolic health.

Share this article

Want the full story? Read the original reporting

Read on Nature